16 results
424B3
HSCS
Heart Test Laboratories Inc.
18 Mar 24
Prospectus supplement
6:06am
modifications to our device, including our proprietary algorithm. We have finished the patient recruitment and core lab work for our FDA validation
8-K
EX-99.1
HSCS
Heart Test Laboratories Inc.
14 Mar 24
HeartSciences Reports Third Quarter Fiscal 2024 Financial Results
4:15pm
of the MyoVista and incorporated AI-ECG algorithm:
Patient recruitment and core-lab work for the MyoVista validation study has been completed
8-K
EX-99.1
HSCS
Heart Test Laboratories Inc.
14 Dec 23
HeartSciences Reports Second Quarter Fiscal 2024 Financial Results
4:07pm
;
Continued progress with the finalization of core-lab work in the MyoVista® validation study following completion of patient recruitment announced earlier
8-K
EX-99.1
2zrgfw1dqwp9gl5vy5as
13 Sep 22
HeartSciences Provides Business Update and Reports First Quarter Fiscal 2023 Financial Results
5:03pm
424B3
jsoqh8omb
5 Aug 22
Prospectus supplement
4:06pm
8-K
EX-99.1
5vyku
5 Aug 22
HeartSciences Provides Corporate Update and Reports Fiscal 2022 Financial Results
1:44pm
10-K
z32pb1kd6ty xjqm7c
29 Jul 22
Annual report
5:01pm
424B4
bklo7spcjux
17 Jun 22
Prospectus supplement with pricing info
3:54pm
FWP
52jxu 1ps9n
6 Jun 22
Free writing prospectus
6:21am
S-1
s2etlwn
17 May 22
IPO registration
5:30pm
DRS/A
g3k8cc2tnr6gora
20 Apr 22
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next